Arcellx pulls in $115m Series C

Arcellx, a clinical-stage biopharmaceutical company, has raised $115 million in Series C financing.

Arcellx, a clinical-stage biopharmaceutical company, has raised $115 million in Series C financing. Samsara BioCapital and CAM Capital led the round.

Source: Press Release